I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 4 studies | 27% ± 2% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| adipocyte | 3 studies | 20% ± 4% | |
| fibroblast | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 4 studies | 27% ± 2% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| adipocyte | 3 studies | 20% ± 4% | |
| fibroblast | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 492.81 | 652 / 653 | 71% | 1.80 | 430 / 605 |
| ovary | 98% | 229.42 | 177 / 180 | 48% | 1.32 | 205 / 430 |
| kidney | 99% | 176.10 | 88 / 89 | 23% | 0.60 | 203 / 901 |
| breast | 99% | 232.61 | 455 / 459 | 18% | 0.51 | 201 / 1118 |
| bladder | 95% | 221.00 | 20 / 21 | 11% | 0.29 | 55 / 504 |
| uterus | 99% | 365.32 | 169 / 170 | 3% | 0.09 | 16 / 459 |
| prostate | 98% | 195.02 | 240 / 245 | 3% | 0.06 | 14 / 502 |
| heart | 99% | 374.26 | 850 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 89% | 209.70 | 1293 / 1445 | 6% | 0.20 | 11 / 183 |
| pancreas | 89% | 114.79 | 292 / 328 | 6% | 0.08 | 11 / 178 |
| spleen | 95% | 147.11 | 229 / 241 | 0% | 0 | 0 / 0 |
| lung | 87% | 96.27 | 500 / 578 | 8% | 0.19 | 91 / 1155 |
| blood vessel | 92% | 164.27 | 1230 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 72% | 60.20 | 187 / 258 | 19% | 0.38 | 44 / 230 |
| intestine | 88% | 230.78 | 851 / 966 | 1% | 0.02 | 7 / 527 |
| brain | 73% | 113.57 | 1917 / 2642 | 10% | 0.23 | 73 / 705 |
| adipose | 77% | 125.69 | 922 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 63% | 86.78 | 227 / 359 | 3% | 0.11 | 10 / 286 |
| skin | 33% | 30.39 | 592 / 1809 | 7% | 0.16 | 35 / 472 |
| liver | 7% | 3.76 | 15 / 226 | 5% | 0.12 | 19 / 406 |
| peripheral blood | 8% | 11.35 | 78 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.10 | 6 / 80 |
| muscle | 4% | 2.39 | 30 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | ZNF208 |
| Protein name | Zinc finger protein 208 (Zinc finger protein 91-like) Zinc finger protein 208 |
| Synonyms | ZNF91L |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | O43345 ENST00000599723.1 ENST00000601993.1 ENST00000397126.9 [O43345-1] M0QYK4 ENST00000599916.5 M0R293 ENST00000597040.1 M0R370 M0QXL7 ENST00000601773.5 M0R1F2 |
